Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946231 · ClinicalTrials.gov registry record
Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home
A clinical trial, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 187
- Enrollment target
NCT00946231 is a clinical trial that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 187 participants.
The verdict
NCT00946231 has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
Study Summary
The HABIT clinical study is being performed to determine the benefit and optimal frequency for at home testing of B-type natriuretic peptide (BNP) for heart failure patients following hospitalization from decompensation. Subjects will be enrolled following hospitalization for decompensated heart failure. Enrolled subjects will be trained on the use of the Triage Touch meter for fingerstick BNP assessment; these subjects will then test their BNP levels daily using the Triage Touch product for approximately 60 days.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00946231
The ClinicalTrials.gov registry entry for NCT00946231 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott RDx Cardiometabolic, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00946231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00946231 about?
NCT00946231 is a clinical study titled "Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home". The HABIT clinical study is being performed to determine the benefit and optimal frequency for at home testing of B-type natriuretic peptide (BNP) for heart failure patients following hospitalization from decompensation. Subjects will be enrolled following hospitalization for decompensated heart fai...
What is the current status of trial NCT00946231?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2009-07. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT00946231?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.